Hormonal Crosstalk Between Thyroid and Breast Cancer
Endocrinology · 01.07.2022 · 163 (7)
DOI: 10.1210/endocr/bqac075 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Endocrinology, online erschienen am 19.05.2022. Verfasst von Stephen Halada und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology and Diabetes, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA. Hauptthemen laut MEDLINE: Breast Neoplasms, Thyroid Neoplasms. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 271 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Institutes of Health, Children’s Hospital of Philadelphia Intramural Frontier Grant.
Abstract (Originalsprache)
Differentiated thyroid cancer and breast cancer account for a significant portion of endocrine-related malignancies and predominately affect women. As hormonally responsive tissues, the breast and thyroid share endocrine signaling. Breast cells are responsive to thyroid hormone signaling and are affected by altered thyroid hormone levels. Thyroid cells are responsive to sex hormones, particularly estrogen, and undergo protumorigenic processes upon estrogen stimulation. Thyroid and sex hormones also display significant transcriptional crosstalk that influences oncogenesis and treatment sensitivity. Obesity-related adipocyte alterations—adipocyte estrogen production, inflammation, feeding hormone dysregulation, and metabolic syndromes—promote hormonal alterations in breast and thyroid tissues. Environmental toxicants disrupt endocrine systems, including breast and thyroid homeostasis, and influence pathologic processes in both organs through hormone mimetic action. In this brief review, we discuss the hormonal connections between the breast and thyroid and perspectives on hormonal therapies for breast and thyroid cancer. Future research efforts should acknowledge and further explore the hormonal crosstalk of these tissues in an effort to further understand the prevalence of thyroid and breast cancer in women and to identify potential therapeutic options.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Endocrinology and Diabetes, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
- Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
- Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
ORCID-Profile: Aime T Franco
Förderung
- NCI NIH HHS
- National Institutes of Health
- Children’s Hospital of Philadelphia Intramural Frontier Grant
Zitieren
APA
Halada, S., Casado-Medrano, V., Baran, J. A., Lee, J., Chinmay, P., Bauer, A. J., & Franco, A. T. (2022). Hormonal Crosstalk Between Thyroid and Breast Cancer. Endocrinology, 163(7). https://doi.org/10.1210/endocr/bqac075
Vancouver
Halada S, Casado-Medrano V, Baran JA, Lee J, Chinmay P, Bauer AJ, et al. Hormonal Crosstalk Between Thyroid and Breast Cancer. Endocrinology. 2022;163(7). doi:10.1210/endocr/bqac075
BibTeX
@article{Halada2022,
author = {Halada, Stephen and Casado-Medrano, Victoria and Baran, Julia A and Lee, Joshua and Chinmay, Poojita and Bauer, Andrew J and Franco, Aime T},
title = {Hormonal Crosstalk Between Thyroid and Breast Cancer},
journal = {Endocrinology},
year = {2022},
volume = {163},
number = {7},
doi = {10.1210/endocr/bqac075}
}
EUVIMED